Skip to content
[P]pubcas
🌐 English
EnglishEnglish简体中文Simplified Chinese繁體中文Traditional ChineseEspañolSpanishFrançaisFrenchDeutschGermanPortuguêsPortugueseРусскийRussianالعربيةArabic日本語Japanese한국어KoreanItalianoItalianNederlandsDutchPolskiPolishTürkçeTurkishTiếng ViệtVietnameseไทยThaiBahasa IndonesiaIndonesianBahasa MelayuMalayहिन्दीHindiবাংলাBengaliاردوUrduفارسیPersianעבריתHebrewУкраїнськаUkrainianRomânăRomanianČeštinaCzechSlovenčinaSlovakMagyarHungarianΕλληνικάGreekБългарскиBulgarianSvenskaSwedishDanskDanishNorsk bokmålNorwegian BokmalSuomiFinnishEestiEstonianLatviešuLatvianLietuviųLithuanianSlovenščinaSlovenianHrvatskiCroatianСрпскиSerbianBosanskiBosnianМакедонскиMacedonianShqipAlbanianAzərbaycanAzerbaijaniქართულიGeorgianՀայերենArmenianҚазақшаKazakhOʻzbekchaUzbekКыргызчаKyrgyzТоҷикӣTajikTürkmençeTurkmenМонголMongolianनेपालीNepaliසිංහලSinhalaதமிழ்TamilతెలుగుTeluguमराठीMarathiગુજરાતીGujaratiಕನ್ನಡKannadaമലയാളംMalayalamਪੰਜਾਬੀPunjabiଓଡ଼ିଆOdiaঅসমীয়াAssameseမြန်မာBurmeseខ្មែរKhmerລາວLaoFilipinoFilipinoKiswahiliSwahiliAfrikaansAfrikaansአማርኛAmharicHausaHausaYorùbáYorubaIgboIgboisiZuluZuluisiXhosaXhosaSoomaaliSomaliMalagasyMalagasyKinyarwandaKinyarwandaChiShonaShonaChichewaChichewaپښتوPashtoسنڌيSindhiKurdîKurdish KurmanjiБеларускаяBelarusianÍslenskaIcelandicGaeilgeIrishCymraegWelshMaltiMalteseEuskaraBasqueCatalàCatalanGalegoGalicianLëtzebuergeschLuxembourgishBasa JawaJavaneseBasa SundaSundaneseKreyòl ayisyenHaitian CreoleMāoriMaoriGagana SamoaSamoanLatinaLatinEsperantoEsperanto
Independent chemical reference Compare
Chemical substance record

Lumiracoxib

220991-20-8C15H13ClFNO2293.725 g/mol

An amino acid that is phenylacetic acid which is substituted at position 2 by the nitrogen of 2-chloro-6-fluoroaniline and at position 5 by a methyl group. A highly selective cyclooxygenase 2 inhibitor, it was briefly used for the treatment of osteoarthritis, but was withdrawn due to concersns of hepatotoxicity. — ChEBI

Quick answers Safety references

Quick answers about Lumiracoxib

Identity · formula · mass

What is Lumiracoxib, CAS 220991-20-8?

Lumiracoxib is the substance linked to CAS 220991-20-8 in ChEBI entry CHEBI:73044. The reported formula is C15H13ClFNO2. Confirm the structural identifiers when distinguishing salts, hydrates, isomers or isotopically labelled materials.

Source ↗

What is the molar mass of Lumiracoxib?

The ChEBI-reported molar mass is 293.725 g/mol for formula C15H13ClFNO2. Its source-reported monoisotopic mass is 293.06188 Da; that uses a specific isotope composition and is a different quantity.

Source ↗

Which PubChem properties are available for Lumiracoxib?

CID 151166 is connected to this record by an exact InChIKey match. PubChem reports exact mass 293.0618845 Da. computed XLogP 4.2. Values and source conventions are shown separately in the property tables below.

Source ↗

Identity & molecular properties

Source-linked values
CAS number220991-20-8ChEBI ↗
Chemical formulaC15H13ClFNO2ChEBI ↗
Molar mass293.725 g/molChEBI ↗
Monoisotopic mass293.06188 DaChEBI ↗
Formal charge0ChEBI ↗
ChEBI identifierCHEBI:73044ChEBI ↗

PubChem molecular properties

PubChem
Molar mass293.72 g/molPubChem ↗
Exact mass293.0618845 DaPubChem ↗
Computed XLogP4.2PubChem ↗
Topological polar surface area (Ų)49.3PubChem ↗
H-bond donors2PubChem ↗
H-bond acceptors4PubChem ↗
Rotatable bonds4PubChem ↗

PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.

Names & structural identifiers

Copy any identifier
lumiracoxib
{2-[(2-chloro-6-fluorophenyl)amino]-5-methylphenyl}acetic acid
KHPKQFYUPIUARC-UHFFFAOYSA-N
Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1
InChI=1S/C15H13ClFNO2/c1-9-5-6-13(10(7-9)8-14(19)20)18-15-11(16)3-2-4-12(15)17/h2-7,18H,8H2,1H3,(H,19,20)

Names & synonyms

lumiracoxibumPrexige{2-[(2-chloro-6-fluorophenyl)amino]-5-methylphenyl}acetic acid

Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.

Classification & relationships

ChEBI ontology

Roles recorded in ChEBI

non-steroidal anti-inflammatory drugantirheumatic drugcyclooxygenase 2 inhibitoranti-inflammatory agent

Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.

Safety documents & references

Supplier matching matters

Find the safety document for your specific supplier, product number and grade.

Find a product-specific SDS

Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.

Mass ↔ amount of substance

Calculated from sourced mass
Equivalent amount
0.00340455 mol

Uses 293.725 g/mol from ChEBI; basis: the substance and formula represented in this record. No purity or concentration correction is applied.

Elemental composition

Theoretical mass fractions
C
Carbon · 15 atoms
61.34%
Cl
Chlorine · 1 atom
12.07%
O
Oxygen · 2 atoms
10.89%
F
Fluorine · 1 atom
6.47%
N
Nitrogen · 1 atom
4.77%
H
Hydrogen · 13 atoms
4.46%

Calculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.

Research & patent references

Selected source associations
Clinical pharmacology of novel selective COX-2 inhibitors. ↗Current pharmaceutical design · 2004 · PMID 14965322
Lumiracoxib (Prexige): a new selective COX-2 inhibitor. ↗International journal of clinical practice · 2004 Jun · PMID 15311562

Sources & record history

Checked 27 Sep 2026
EMBL-EBI ChEBI · CHEBI:73044

Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0

NCBI PubChem · CID 151166 · retrieved 2026-09-27

PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.